Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy
Clinical trial NCT03436693 · COMPLETED
Trial details
- NCT number
- NCT03436693
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-15
- Primary completion
- 2021-01-21
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.